Intracerebral Hemorrhage News and Research

RSS
Intracerebral hemorrhage (ICH) is sudden, catastrophic bleeding that occurs in the brain tissue or ventricles. It usually results from damage to blood vessels due to hypertension. Symptoms are often sudden and severe. Loss of consciousness, vomiting, and headache are all common, but milder presentations are also possible, resembling ischemic stroke.
SIRO Clinpharm announces alliance with DreamCIS CRO

SIRO Clinpharm announces alliance with DreamCIS CRO

LPC Pharma Group outsources pharmacovigilance/drug safety operations to APCER Pharma

LPC Pharma Group outsources pharmacovigilance/drug safety operations to APCER Pharma

MEND Program: Effective treatment for pediatric obesity

MEND Program: Effective treatment for pediatric obesity

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

Sanofi Pasteur expands dengue vaccine clinical program in Latin America

Sanofi Pasteur expands dengue vaccine clinical program in Latin America

ARYx Therapeutics announces operating results for the third quarter of 2009

ARYx Therapeutics announces operating results for the third quarter of 2009

USP offers redesigned pharmaceutical standards format to improve key documentation process

USP offers redesigned pharmaceutical standards format to improve key documentation process

Histostem awarded U.S. patent for isolation of mesenchymal stem cells

Histostem awarded U.S. patent for isolation of mesenchymal stem cells

Positive results from Peregrine's Phase II bavituximab trial for non-small cell lung cancer

Positive results from Peregrine's Phase II bavituximab trial for non-small cell lung cancer

Æterna Zentaris announces results of its cetrorelix pamoate clinical development program TQT trial

Æterna Zentaris announces results of its cetrorelix pamoate clinical development program TQT trial

Stem Cell Therapy International merges with Histostem

Stem Cell Therapy International merges with Histostem

Patient enrollment completed in Phase II clinical trial of bavituximab

Patient enrollment completed in Phase II clinical trial of bavituximab

ERT celebrates a significant milestone: Completes 150Th QT clinical Trial

ERT celebrates a significant milestone: Completes 150Th QT clinical Trial

The 4th annual OPENeCTD forum to be hosted by EXTEDO

The 4th annual OPENeCTD forum to be hosted by EXTEDO

Interim Phase II data of Cotara reveals signs of efficacy in GBM patients

Interim Phase II data of Cotara reveals signs of efficacy in GBM patients

FDA recommends electronic report formats to strengthen postmarket safety data collection

FDA recommends electronic report formats to strengthen postmarket safety data collection

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

PerkinElmer launched its second Good Manufacturing Practice facility for radiosynthesis of potential drug compounds

PerkinElmer launched its second Good Manufacturing Practice facility for radiosynthesis of potential drug compounds

ECOSOC's agenda should include noncommunicable disease threat in developing countries

ECOSOC's agenda should include noncommunicable disease threat in developing countries

Clot-buster boosts survival, decreases disability for deadly subset of stroke

Clot-buster boosts survival, decreases disability for deadly subset of stroke